BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12046850)

  • 1. Hematopoietic stem cell gene therapy for inherited bone marrow disorders: past accomplishments and continued challenges.
    Becker PS
    J Cell Biochem Suppl; 2002; 38():55-64. PubMed ID: 12046850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical gene therapy in hematology: past and future.
    Richter J; Karlsson S
    Int J Hematol; 2001 Feb; 73(2):162-9. PubMed ID: 11372727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell gene transfer for the treatment of hemoglobin disorders.
    Persons DA
    Hematology Am Soc Hematol Educ Program; 2009; ():690-7. PubMed ID: 20008255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retroviral transduction of murine and human hematopoietic progenitors and stem cells.
    Ciuculescu MF; Brendel C; Harris CE; Williams DA
    Methods Mol Biol; 2014; 1185():287-309. PubMed ID: 25062637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of introduced genetic sequences in hematopoietic cells following retroviral-mediated gene transfer.
    Williams DA
    Hum Gene Ther; 1990; 1(3):229-39. PubMed ID: 1964394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
    Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
    Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy Approaches to Hemoglobinopathies.
    Ferrari G; Cavazzana M; Mavilio F
    Hematol Oncol Clin North Am; 2017 Oct; 31(5):835-852. PubMed ID: 28895851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transduction of Murine Hematopoietic Stem Cells with Tetracycline-regulated Lentiviral Vectors.
    Stahlhut M; Schambach A; Kustikova OS
    Methods Mol Biol; 2016; 1448():65-76. PubMed ID: 27317173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enrichment of human hematopoietic stem/progenitor cells facilitates transduction for stem cell gene therapy.
    Baldwin K; Urbinati F; Romero Z; Campo-Fernandez B; Kaufman ML; Cooper AR; Masiuk K; Hollis RP; Kohn DB
    Stem Cells; 2015 May; 33(5):1532-42. PubMed ID: 25588820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transduction events in retrovirus-mediated gene therapy involving hematopoietic stem cells: beyond efficiency issues.
    Medin JA; Fowler DH
    J Cell Biochem Suppl; 2002; 38():46-54. PubMed ID: 12046849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The third conference on hematopoietic stem cell gene therapy: biology and technology.
    Emery DW; Bodine DM
    Mol Ther; 2002 Jun; 5(6):658-63. PubMed ID: 12027548
    [No Abstract]   [Full Text] [Related]  

  • 12. Production of human glucocerebrosidase in mice after retroviral gene transfer into multipotential hematopoietic progenitor cells.
    Correll PH; Fink JK; Brady RO; Perry LK; Karlsson S
    Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8912-6. PubMed ID: 2573069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of View.
    Cavazzana M; Ribeil JA; Lagresle-Peyrou C; André-Schmutz I
    Stem Cells Dev; 2017 Jan; 26(2):71-76. PubMed ID: 27750026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward gene therapy for Gaucher disease.
    Kohn DB; Nolta JA; Weinthal J; Bahner I; Yu XJ; Lilley J; Crooks GM
    Hum Gene Ther; 1991; 2(2):101-5. PubMed ID: 1911928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term engraftment of nonobese diabetic/severe combined immunodeficient mice with human CD34+ cells transduced by a self-inactivating human immunodeficiency virus type 1 vector.
    Gatlin J; Padgett A; Melkus MW; Kelly PF; Garcia JV
    Hum Gene Ther; 2001 Jun; 12(9):1079-89. PubMed ID: 11399229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5.
    Zhong L; Li W; Li Y; Zhao W; Wu J; Li B; Maina N; Bischof D; Qing K; Weigel-Kelley KA; Zolotukhin I; Warrington KH; Li X; Slayton WB; Yoder MC; Srivastava A
    Hum Gene Ther; 2006 Mar; 17(3):321-33. PubMed ID: 16544981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
    Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
    Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation.
    Mostoslavsky G; Kotton DN; Fabian AJ; Gray JT; Lee JS; Mulligan RC
    Mol Ther; 2005 Jun; 11(6):932-40. PubMed ID: 15922964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective expansion of transduced cells for hematopoietic stem cell gene therapy.
    Kume A; Hanazono Y; Mizukami H; Okada T; Ozawa K
    Int J Hematol; 2002 Nov; 76(4):299-304. PubMed ID: 12463591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
    Hanenberg H; Roellecke K; Wiek C
    Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.